Trials / Completed
CompletedNCT04197778
Food Effect Study of DDO-3055 Tablets in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is a randomized , open-label, two-stage crossover food effect study of single doses of DDO-3055 tablets in healthy subjects. 14 healthy subjects were randomly divided into groups A and B, 7 subjects in each group. Two stage washout period is 6 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DDO-3055 tablet | DDO-3055 tablet, 2 single doses separated by 6 days. |
Timeline
- Start date
- 2020-01-06
- Primary completion
- 2020-01-18
- Completion
- 2020-01-18
- First posted
- 2019-12-13
- Last updated
- 2022-06-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04197778. Inclusion in this directory is not an endorsement.